Shijiazhuang Auro Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shijiazhuang Auro Technology Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include PRINUMB. The owner is based in Shijiazhuang, Heibei.

#508 Zhongshan East Rd, Chang'an Dist

1501, Bldg B, Dongsheng Plaza

Shijiazhuang, Heibei 050000 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shijiazhuang Auro Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shijiazhuang Auro Technology Co., Ltd. have?

Shijiazhuang Auro Technology Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending.

What trademark classes does Shijiazhuang Auro Technology Co., Ltd. file in?

Shijiazhuang Auro Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shijiazhuang Auro Technology Co., Ltd.'s most well-known trademarks?

Shijiazhuang Auro Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as PRINUMB. These are among 1 currently registered trademark in the portfolio.

What is Shijiazhuang Auro Technology Co., Ltd.'s trademark registration success rate?

Shijiazhuang Auro Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.